S. Weiss Michael's Insider Trades & SAST Disclosures
S. Weiss Michael's most recent trade in TG Therapeutics Inc was a trade of 750,000 Common Stock done . Disclosure was reported to the exchange on Jan. 29, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern S. Weiss Michael.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TG Therapeutics Inc | Michael S. Weiss | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 750,000 | 13,824,929 (12%) | 0% | 0 | Common Stock | |
| Fortress Biotech Inc | Michael S. Weiss | Director, Executive Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 454,153 | 1,801,138 (2%) | 0% | 0 | common stock, par value $0.001 | |
| Checkpoint Therapeutics Inc | Michael S. Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2024 | 12,638 | 124,812 (0%) | 0% | 0 | COMMON STOCK | |
| Checkpoint Therapeutics Inc | Michael S. Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 50,000 | 112,174 (0%) | 0% | 0 | COMMON STOCK | |
| Checkpoint Therapeutics Inc | Michael S. Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 32,051 | 62,174 (0%) | 0% | 0 | COMMON STOCK | |
| TG Therapeutics Inc | S. Weiss Michael | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 1,001,908 | 13,074,929 (11%) | 0% | 0 | Common Stock | |
| Fortress Biotech Inc | Michael Weiss S. | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 216,465 | 1,346,985 (1%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| TG Therapeutics Inc | Michael S. Weiss | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 10.13 per share. | 11 Aug 2023 | 100,000 | 12,073,021 (11%) | 0% | 10.1 | 1,013,000 | COMMON STOCK |
| Mustang Bio Inc | Michael S. Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 7,246 | 49,637 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.0001 | |
| Checkpoint Therapeutics Inc | Michael S. Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 17,483 | 30,123 (0%) | 0% | 0 | COMMON STOCK | |
| TG Therapeutics Inc | Michael S. Weiss | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2023 | 985,000 | 11,973,021 (10%) | 0% | 0 | COMMON STOCK | |
| Fortress Biotech Inc | Michael S. Weiss | Director, See Remarks, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 10 Feb 2023 | 1,197,604 | 14,752,034 (20%) | 1% | 0.8 | 999,999 | COMMON STOCK, PAR VALUE $0.001 |
| Fortress Biotech Inc | Michael S. Weiss | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 1,219,294 | 13,554,430 (19%) | 1% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Mustang Bio Inc | Michael S. Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2022 | 71,664 | 135,861 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.0001 | |
| Fortress Biotech Inc | Michael S. Weiss | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 1,102,986 | 12,335,136 (17%) | 1% | 0 | Common Stock | |
| Mustang Bio Inc | Michael S. Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2021 | 13,774 | 64,197 (0%) | 0% | 0 | COMMON STOCK | |
| TG Therapeutics Inc | Michael S. Weiss | Director, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2020 | 834,877 | 13,071,837 (11%) | 0% | 0 | COMMON STOCK | |
| TG Therapeutics Inc | Michael S. Weiss | Director, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2020 | 525,000 | 13,909,214 (12%) | 0% | 0 | COMMON STOCK | |
| TG Therapeutics Inc | Michael S. Weiss | Director, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2020 | 2,500 | 13,906,714 (12%) | 0% | 0 | COMMON STOCK | |
| TG Therapeutics Inc | Michael S. Weiss | Director, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2020 | 1,700 | 13,070,137 (11%) | 0% | 0 | COMMON STOCK | |
| TG Therapeutics Inc | Michael S. Weiss | Director, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2020 | 1,000 | 13,068,737 (11%) | 0% | 0 | COMMON STOCK | |
| TG Therapeutics Inc | Michael S. Weiss | Director, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2020 | 655 | 13,068,082 (11%) | 0% | 0 | COMMON STOCK | |
| TG Therapeutics Inc | Michael S. Weiss | Director, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2020 | 200 | 13,069,737 (11%) | 0% | 0 | COMMON STOCK | |
| TG Therapeutics Inc | Michael S. Weiss | Director, CEO and President | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2020 | 200 | 13,069,937 (11%) | 0% | 0 | COMMON STOCK | |
| Mustang Bio Inc | Michael S. Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2020 | 16,611 | 50,423 (0%) | 0% | 0 | Common Stock | |
| TG Therapeutics Inc | Michael S. Weiss | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 1,556,029 | 14,434,214 (13%) | 1% | 0 | COMMON STOCK | |
| Checkpoint Therapeutics Inc | Michael S. Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 24,390 | 62,280 (0%) | 0% | 0 | COMMON STOCK |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges